wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36153347-0EB78261-5092-40AE-9AE7-0884CB3E33AA
Q36153347-0EB78261-5092-40AE-9AE7-0884CB3E33AA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36153347-0EB78261-5092-40AE-9AE7-0884CB3E33AA
Humoral response to catumaxomab correlates with clinical outcome: results of the pivotal phase II/III study in patients with malignant ascites
P2860
Q36153347-0EB78261-5092-40AE-9AE7-0884CB3E33AA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36153347-0EB78261-5092-40AE-9AE7-0884CB3E33AA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
00616de5496ddb5fbace3a627cfa4f478acea9b7
P2860
Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy.